Michigan / Karmanos Cancer Center
CMS certification 230297 · Detroit, MI · 3 entries in CMS's price-transparency list
Karmanos Cancer Center: charges and Medicare payments
Karmanos Cancer Center reported 110 Medicare inpatient stays across 6 DRGs in 2024. Across them it charged 2.98 times what it was paid — mid-range in Michigan, number 44 of 76 hospitals with at least 100 stays (state median 3.09×, national 4.15×). Its most frequent stay was DRG 871, Septicemia or Severe Sepsis without MV >96 Hours with MCC: 31 stays at an average charge of $67,051, 26% below the national average. It also billed 982 outpatient services, charging 5.73 times what Medicare paid.
- 1Medicare inpatient stays 110
- 2Charge ÷ paid, inpatient 2.98×
- 3Rank in MI (highest ratio = 1) 44 of 76
- 4CMS price-transparency actions 3
Inpatient stays
For the 6 DRGs that can be compared with the national average, Karmanos Cancer Center charged more than the national average in 0 (0%). Payments follow Medicare's rates, so they usually vary far less than charges.
| DRG | Stays | Avg charge | vs US | Avg paid |
|---|---|---|---|---|
| 871 Septicemia or Severe Sepsis without MV >96 Hours with MCC | 31 | $67,051 | -26% | $18,753 |
| 016 Autologous Bone Marrow Transplant with CC/MCC | 23 | $121,711 | -56% | $51,187 |
| 014 Allogeneic Bone Marrow Transplant | 17 | $526,137 | -9% | $158,172 |
| 837 Chemotherapy with Acute Leukemia As Secondary Diagnosis or... | 15 | $87,865 | -62% | $40,442 |
| 847 Chemotherapy without Acute Leukemia As Secondary Diagnosis... | 13 | $34,631 | -49% | $10,360 |
| 164 Major Chest Procedures with CC | 11 | $53,013 | -58% | $21,281 |
Outpatient services
Against the Michigan average
For Septicemia or Severe Sepsis without MV >96 Hours with MCC (DRG 871), Karmanos Cancer Center charged $67,051 on average, 24% more than the Michigan average of $54,260, and was paid $18,753 against a state average of $17,096. For Autologous Bone Marrow Transplant with CC/MCC (DRG 016), Karmanos Cancer Center charged $121,711 on average, 43% less than the Michigan average of $215,151, and was paid $51,187 against a state average of $74,380. For Allogeneic Bone Marrow Transplant (DRG 014), Karmanos Cancer Center charged $526,137 on average, 20% more than the Michigan average of $440,194, and was paid $158,172 against a state average of $149,380. For Chemotherapy with Acute Leukemia As Secondary Diagnosis or with High Dose Chemotherapy A (DRG 837), Karmanos Cancer Center charged $87,865 on average, 31% less than the Michigan average of $127,913, and was paid $40,442 against a state average of $56,009. For Level 2 Excision/ Biopsy/ Incision and Drainage (outpatient APC 5072), its average charge of $6,019 was 18% below the state average of $7,344. For Level 2 Urology and Related Services (outpatient APC 5372), its average charge of $3,270 was 45% above the state average of $2,258. For Level 3 Excision/ Biopsy/ Incision and Drainage (outpatient APC 5073), its average charge of $10,631 was 22% below the state average of $13,653. For Level 3 Vascular Procedures (outpatient APC 5183), its average charge of $14,514 was 7% below the state average of $15,679.
Price-transparency record
CMS's enforcement list records these actions for a hospital named Karmanos Cancer Center in Detroit, MI, under the federal hospital price-transparency rule (45 CFR part 180), which requires hospitals to post their standard charges online:
- Warning Notice — 2024-10-02 (CMS case 2755)
- Closure Notice — 2024-10-15 (CMS case 2755)
- Met Requirements — 2025-05-28 (CMS case 4744)
A warning notice or corrective-action request is not a finding of wrongdoing; "Met Requirements" and closure notices record that CMS's review ended. Matched to this hospital by exact name, city and state.
Charges are the hospital's list prices averaged over its 2024 Medicare cases; payments are what those cases actually brought in. Neither is what you will pay. For a planned procedure, ask the hospital for its price estimate or, if you are uninsured or self-paying, a good-faith estimate.
Sources: CMS Medicare Inpatient Hospitals — by Provider and Service / by Geography and Service, data year 2024; CMS Medicare Outpatient Hospitals — by Provider and Service / by Geography and Service, data year 2024; CMS Hospital Price Transparency Enforcement Activities and Outcomes, July 2026. Checked 2026-10-24. Methodology.